Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Roka

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Breast (Edinburgh, Scotland)|June 15, 2007
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancerPeter Konstantiniuk, Peter Schrenk, Roland Reitsamer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 8, 2019
Systemic inflammatory response after hyperthermic intraperitoneal chemotherapy (HIPEC): The perfusion protocol matters!Lilian Roth, Dilmurodjon Eshmuminov, Felix Laminger, et al.
Wiener Klinische Wochenschrift|March 20, 2004
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Clinical Breast Cancer|May 22, 2002
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancerPeter C Dubsky, Michael F X Gnant, Susanne Taucher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifenThomas Bachleitner-Hofmann, Barbara Pichler-Gebhard, Margarethe Rudas, et al.
Cancer|November 6, 2003
Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapyChristine Brostjan, Anita Bayer, Anna Zommer, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Wiener Klinische Wochenschrift|March 2, 2012
[Consensus statement haemorrhoidal disease]Felix Aigner, Friedrich Conrad, Ingrid Haunold, et al.
Annals of Surgery|October 11, 2018
Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal OriginMarcel André Schneider, Janina Eden, Basile Pache, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Breast (Edinburgh, Scotland)|June 15, 2007
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancerPeter Konstantiniuk, Peter Schrenk, Roland Reitsamer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 8, 2019
Systemic inflammatory response after hyperthermic intraperitoneal chemotherapy (HIPEC): The perfusion protocol matters!Lilian Roth, Dilmurodjon Eshmuminov, Felix Laminger, et al.
Wiener Klinische Wochenschrift|March 20, 2004
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Clinical Breast Cancer|May 22, 2002
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancerPeter C Dubsky, Michael F X Gnant, Susanne Taucher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifenThomas Bachleitner-Hofmann, Barbara Pichler-Gebhard, Margarethe Rudas, et al.
Cancer|November 6, 2003
Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapyChristine Brostjan, Anita Bayer, Anna Zommer, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Wiener Klinische Wochenschrift|March 2, 2012
[Consensus statement haemorrhoidal disease]Felix Aigner, Friedrich Conrad, Ingrid Haunold, et al.
Annals of Surgery|October 11, 2018
Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal OriginMarcel André Schneider, Janina Eden, Basile Pache, et al.
Pageof 2